CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Effects of Imatinib mesylate on the radio- and chemosensitivity of breast carcinoma cell lines
DOI 10.1055/s-0028-1088691
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMT Weigel, K Weber, N Maass, W Jonat, C Mundhenke
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Breast cancer treatment is based on a combination of adjuvant chemotherapy followed by radiotherapy. With the tyrosine kinase inhibitors new targeted drugs are available like Imatinib mesylate, a selective inhibitor of bcr-abl, PRGFR α, β and c-kit. The purpose of this study was to determine whether Imatinib has an influence on the effectiveness of radiotherapy in breast cancer cell lines and if a combination of Ima…
Zitieren
Zitierempfehlung
MT Weigel, K Weber, N Maass, W Jonat, C Mundhenke (2008) Effects of Imatinib mesylate on the radio- and chemosensitivity of breast carcinoma cell lines. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-0028-1088691
Mit CareLit weiterarbeiten